| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Medpace Holdings, Inc. (MEDP) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. MEDP is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 646.2K | $273.83M | - | |
| Other | 28.6K | $12.11M | - | |
| Dir | 26.3K | $11.14M | - | |
| Pres | 15.0K | $6.36M | - | |
| VP | 11.0K | $4.65M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2024 | Burwig Susan E64 | Exec. VP, Operations | Sell | 102 | $403.00 | $41,106.00 | -0.7% | -0.7% | -18.1% | |
| Mar 14, 2024 | Keating Ashley M.67 | Director | Sale+OE | 250 | $409.87 | $102,467.50 | -50.0% | -0.2% | -19.7% | |
| Mar 8, 2024 | Medpace Investors, LLC69 | 10% Owner | Sell | 200,000 | $411.61 | $82,321,250.00 | -1.4% | -0.6% | -18.0% | |
| Mar 8, 2024 | Troendle August J.71 | CEO | Sell | 200,000 | $411.61 | $82,321,250.00 | -1.4% | -0.6% | -18.0% | |
| Mar 7, 2024 | Keating Ashley M.67 | Director | Sale+OE | 472 | $415.00 | $195,880.00 | -100% | -0.5% | -18.8% | |
| Mar 5, 2024 | Troendle August J.71 | CEO | Sell | 100,000 | $402.91 | $40,291,000.00 | -1.0% | -3.4% | -18.5% | |
| Mar 5, 2024 | Medpace Investors, LLC69 | 10% Owner | Sell | 100,000 | $402.91 | $40,291,000.00 | -1.0% | -3.4% | -18.5% | |
| Mar 4, 2024 | Geiger Jesse J60 | President | Sale+OE | 22,321 | $403.03 | $8,996,032.63 | -85.4% | -3.2% | -19.4% | |
| Mar 1, 2024 | Medpace Investors, LLC69 | 10% Owner | Sell | 100,000 | $400.25 | $40,024,600.00 | -1.0% | -4.6% | -19.0% | |
| Mar 1, 2024 | Troendle August J.71 | CEO | Sell | 100,000 | $400.25 | $40,024,600.00 | -1.0% | -4.6% | -19.0% |